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ARTICLE

Viral MHCI inhibition evades tissue-resident memory
T cell formation and responses
Tissue-resident memory CD8+ T cells (TRMs) confer rapid protection and immunity against viral infections. Many viruses
have evolved mechanisms to inhibit MHCI presentation in order to evade CD8+ T cells, suggesting that these mechanisms
may also apply to TRM-mediated protection. However, the effects of viral MHCI inhibition on the function and generation
of TRMs is unclear. Herein, we demonstrate that viral MHCI inhibition reduces the abundance of CD4+ and CD8+ TRMs, but
its effects on the local microenvironment compensate to promote antigen-specific CD8+ TRM formation. Unexpectedly,
local cognate antigen enhances CD8+ TRM development even in the context of viral MHCI inhibition and CD8+ T cell evasion,
strongly suggesting a role for in situ cross-presentation in local antigen-driven TRM differentiation. However, local cognate
antigen is not required for CD8+ TRM maintenance. We also show that viral MHCI inhibition efficiently evades CD8+ TRM
effector functions. These findings indicate that viral evasion of MHCI antigen presentation has consequences on the
development and response of antiviral TRMs.

Introduction

CD8+ T cells mediate potent immunity against viral infections
and respond to foreign antigens presented by major histocompatibility complex class I (MHCI) molecules (Schmitz et al., 1999;
Shoukry et al., 2003; Simon et al., 2006). The importance of MHCI
antigen presentation is underscored by the fact that viruses have
evolved strategies to block MHCI presentation. For instance, cowpox virus (CPXV) inhibits MHCI presentation by two distinct
mechanisms. The CPXV203 protein retains MHCI molecules in
the ER (Byun et al., 2007), whereas the CPXV012 protein prevents
the transporter associated with antigen processing from loading
antigen peptides onto MHCI molecules (Alzhanova et al., 2009;
Byun et al., 2009). When combined, these mechanisms result in
effective evasion of CD8+ T cell responses in vivo, and the absence
of the CPXV012 and CPXV203 significantly attenuates CPXV in a
CD8+ T cell–dependent manner (Byun et al., 2009; Gainey et al.,
2012; Lauron et al., 2018). Moreover, the ability to inhibit MHCI
presentation appears to be an evolutionarily conserved feature,
though mechanistically distinct, among CMVs and other viruses
(Hansen and Bouvier, 2009). Viral MHCI inhibition evades CD8+
T cell responses against murine CMV infection in the salivary
glands of naive hosts and is critical in allowing for rhesus CMV
superinfection of hosts harboring memory CD8+ T cells (Lu et
al., 2006; Hansen et al., 2010). However, tissue-resident mem-

ory CD8+ T cells (TRMs) are able to protect against local infection
when murine CMV is directly introduced into the salivary glands,
likely due to an early viral tropism for cells refractory to viral
MHCI inhibition (Thom et al., 2015). Therefore, the effects of
viral MHCI inhibition on CD8+ TRM responses remain unclear.
CD8+ TRMs typically form in nonlymphoid tissues following
viral infection and are a noncirculating subset of memory T cells,
whereas the effector memory T cell (TEM) and central memory T
cell (TCM) subsets continuously recirculate (Carbone, 2015). Because CD8+ TRMs primarily develop and remain at common sites
of pathogen entry, they are considered a frontline defense against
secondary or recurrent peripheral infections; both CD8+ and CD4+
TRMs promote viral control and survival against lethal infection,
mediate cross-strain protection, and even provide better protection than the circulating TEM and TCM counterparts (Gebhardt et
al., 2009; Teijaro et al., 2011; Jiang et al., 2012; Mackay et al., 2012;
Wu et al., 2014; Zens et al., 2016).
The factors driving TRM development have implications for
tissue-specific vaccine strategies. For example, the “prime and
pull” strategy demonstrates that CD8+ T cells can be recruited
to the skin or vagina in an antigen-independent manner and
drive TRM formation, resulting in long-term immunity against
local challenge (Mackay et al., 2012; Shin and Iwasaki, 2012).
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Results

Viral MHCI inhibition affects the formation of CD4+ TRMs
but not CD8+ TRMs
CPXV-mediated MHCI inhibition could reduce local antigenic
stimulation of virus-specific CD8+ T cells by infected cells. Because local antigenic stimulation enhances CD8+ TRM formation
during vaccinia virus (VACV) skin infection (Khan et al., 2016),
we hypothesized that CD8+ TRM formation would be diminished
in CPXV-infected skin. To test this, we infected mice by skin scarification (s.s.) with WT CPXV or Δ12Δ203 CPXV, which does not
inhibit MHCI antigen presentation, and performed kinetic analyses of CD8+ T cells that recognize the immunodominant H-2Kb–
restricted epitope B819–26. Infection with both viruses resulted
in robust expansion and recruitment of B819–26-specific CD8+
T cells to the skin 1 wk after infection, which were reduced in
numbers ∼12-fold by 3 wk after infection (Fig. 1 A). Nonetheless,
B819–26-specific CD8+ T cells were still detectable in the skin and
the spleens of previously infected mice long after clearance of the
infection (Fig. 1, A–D). CPXV skin infections are highly localized
and are cleared within 1–2 wk after infection (Gainey et al., 2012).
Mice infected with WT CPXV had a higher relative abundance of
B819–26-specific CD8+ T cells in the skin at 7 d postinfection (dpi)
in comparison to Δ12Δ203-infected mice (Fig. 1, C and D), but
there were no significant differences in absolute numbers in the
skin for all assessed time points.
Analysis of B819–26-specific CD8+ T cells during the memory
phase showed that they were predominantly located in the preLauron et al.
Viral evasion of TRM immunity

viously infected skin flank relative to the uninfected contralateral flank (Fig. 1 B). These findings are consistent with previous
reports (Gebhardt et al., 2009; Khan et al., 2016; Muschaweckh
et al., 2016). We show that these cells expressed higher levels of
the TRM markers CD103 and CD69 than the B819–26-specific CD8+
T cells in the spleen (Fig. 1, E and F), suggesting that CPXV s.s.
infection generates authentic CD8+ TRMs. To verify tissue residency of CD103+CD69+CD8+ cells, we performed parabiosis between CD45.1+ naive mice and CD45.2+ mice previously infected
with CPXV, referred to as naive and memory mice, respectively
(Fig. 1 G). Comparison of the CD45.2+CD45.1−CD103+CD69+CD8+
TRMs in the skin of naive and memory parabionts revealed the
presence of these cells in only the memory parabionts, showing
that they are unable to circulate and are indeed a resident population (Fig. 1, H and I). Furthermore, CD45.2+CD45.1−B819–26tetramer+ cells in the spleens equilibrated between memory and
naive parabionts, but CD45.2+CD45.1−B819–26-tetramer+ TRMs in
the skin were only present in memory parabionts (Fig. 1, J and
K). Regarding CD4+ TRM, CPXV s.s. generated CD103+CD69+CD4+
T cells in the skin in comparable numbers to CD8+ TRM, and
parabiosis revealed that these cells were bona fide skin-resident CD4+ T cells (Fig. 2, A–C). Interestingly, we found that viral
MHCI inhibition significantly reduced the abundance of these
CD103+CD69+CD4+ T cells in the skin (Fig. 2, A and B). Taken together, these results reveal that viral MHCI inhibition does not
affect the overall development of CD8+ TRMs but does impair the
formation of CD4+ TRMs in the skin.
We reasoned that the effects of viral MHCI inhibition on local
CPXV-specific CD8+ T cells might have direct or indirect consequences on the development of CD4+ TRMs. To gain insight into
how viral MHCI inhibition affects local antigen-specific CD8+
T cells, we performed RNA sequencing (RNA-seq) on B819–26specific CD8+ T cells isolated from the skin and spleen of mice
coinfected with WT CPXV and Δ12Δ203 on opposite flanks. At
7 dpi, B819–26-specific CD8+ T cells isolated from WT CPXV and
Δ12Δ203-infected skin exhibited similar expression profiles and
shared many differentially expressed genes relative to splenic
B819–26-specific CD8+ T cells (Fig. S1, A and B). Gene set enrichment analysis (GSEA) of unique differentially expressed genes
revealed significant enrichment of genes associated with activation of lymphocytes in Δ12Δ203-infected skin, while analysis of
B819–26-specific CD8+ T cells from WT CPXV–infected skin demonstrated expression of genes involved in the regulation of cytokine
production (Fig. S1 C). Cytokines that were significantly up-regulated in WT CPXV–infected skin were also significantly up-regulated in Δ12Δ203-infected skin (Fig. S1 D). However, we found that
IL-10 expression by B819–26-specific CD8+ T cells was significantly
higher in WT-infected skin in comparison to Δ12Δ203-infected
skin, both at the transcript and protein levels (Fig. S1, E–G). The
increased IL-10 production correlates with the reduced number
of CD4+ TRM in WT CPXV–infected skin. IL-10 has been shown to
reduce the number of circulating memory CD4+ T cells following
acute infection with lymphocytic choriomeningitis virus (Brooks
et al., 2010). Therefore, these findings could explain why viral
MHCI evasion affects CD4+ TRM formation.
CD4+ T cell help is critical for the local development of lung
CD8+ TRMs (Laidlaw et al., 2014) but dispensable for the formaJournal of Experimental Medicine
https://doi.org/10.1084/jem.20181077
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Conversely, recruitment or inflammation alone does not generate TRMs in the lungs unless local cognate antigen is present
(Takamura et al., 2016; McMaster et al., 2018), indicating tissue-specific requirements for local cognate antigen during TRM
differentiation. Depots of persisting viral antigens in the lung
may also affect the maintenance of memory T cells (Zammit
et al., 2006; Lee et al., 2011). However, it is unknown whether
persistent antigen presentation occurs in the skin or if MHCI
complexes are important for the maintenance of endogenous
skin CD8+ TRMs. In the context of viral infections, local cognate
antigen recognition promotes the formation of CD8+ TRMs in the
skin and is required for CD8+ TRM formation in the central nervous system, peripheral nervous system, and lungs (Wakim et al.,
2010; Mackay et al., 2012; Khan et al., 2016; Muschaweckh et al.,
2016; Pizzolla et al., 2017).
These findings on the potential role of local antigen during
viral infection raise an interesting question: can viral MHCI inhibition affect local antigen recognition and reduce CD8+ TRM
formation? To investigate this issue, we compared CD8+ TRM formation and protection following local infection with CPXV and a
CPXV mutant lacking the capacity to inhibit MHCI presentation.
Surprisingly, viral MHCI inhibition affected CD4+ TRM formation,
but not the overall development CD8+ TRM formation, in the skin.
We found that local secondary antigenic stimulation promoted
CD8+ TRM formation, despite CPXV-mediated MHCI inhibition and
CD8+ T cell evasion. After TRM differentiation, local cognate antigen presentation was dispensable for TRM maintenance but was
critical in infected cells to induce protective CD8+ TRM responses.
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Figure 1. Viral MHCI inhibition does not affect the overall development of CD8+ TRMs. (A–F) C57BL/6 mice were infected by s.s. with WT CPXV or Δ12Δ203.
(A) The absolute number of B819–26-tetramer+ cells in the skin (S) and spleen (Sp) of infected mice over time (n = 4 mice per time point). (B) The absolute
number of B819–26-tetramer+ cells in previously infected skin flank and the contralateral uninfected skin flank at 49 dpi. (C) Representative flow plots of B819–26tetramer+ cells in the skin at the indicated time points. (D) Percentage (top) and absolute number (bottom) of B819–26-tetramer+ cells in the skin at 7 and 35 dpi.
(E) Representative flow plots of CD103 and CD69 expression on B819–26-tetramer+ cells are shown for the indicated time points. (F) Percentage of CD103 (left)
and CD69 (right) expression on B819–26-tetramer+ cells are shown for the indicated time points. (G) Schematic of the parabiosis experiment. (H) Representative flow plots of CD45.2+CD45.1–CD103+CD69+CD8+ T cells in the skin of parabiosed mice. (I) Percentage and absolute numbers of CD45.2+CD45.1−CD103+
CD69+CD8+ T cells in the skin of parabiosed mice. (J) Absolute number of CD45.2+CD45.1−B819–26-tetramer+ TRMs in the skin of parabiosed mice. (K) Percentage
Lauron et al.
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Local cognate antigen enhances CD8+ TRM formation, despite
effective viral MHCI inhibition and CD8+ T cell evasion
Since CD8+ TRM development occurred despite viral MHCI inhibition, we tested if CD8+ TRM formation is independent of local
antigen. To this end, we performed coinfections on opposite
flanks with CPXV viruses that express either a WT (WT and
Δ12Δ203-CPXV) or a variant of the immunodominant B819–26 epitope (B8Y3AF5A and Δ12Δ203B8Y3AF5A) that is not presented
on MHCI (Lauron et al., 2018; Fig. 3 A). During the acute phase
of infection, B819–26-specific CD8+ T cells had modestly higher
frequencies of CD69 expression in the skin where B819–26 was
expressed in comparison to the skin where the B819–26 epitope
was absent, whereas CD103 expression was unaffected (Fig. S2, A
and B). Nonetheless, a similar percentage and number of B819–26specific CD8+ T cells were recruited to both infected skin flanks
in a local antigen-independent manner (Fig. 3 B). This was also
the case when coinfections were performed with Δ12Δ203 and
Δ12Δ203B8Y3AF5A. At 35 dpi, however, B819–26-specific TRMs
were significantly enriched in the skin where B819–26 was locally

expressed as compared with infection where B819–26 was locally
absent (Fig. 3 C), even in the presence of CPXV-mediated MHCI
inhibition. Furthermore, the abundance of total CD8+ TRM was
equal on both flanks of coinfected mice (Fig. 3 D), suggesting that
TRM formation was only affected for B819–26-specific CD8+ T cells.
Taken together, these data indicate that local antigen does promote CD8+ TRM formation during CPXV infection, regardless of
viral MHCI inhibition.
Viral MHCI inhibition affects CD8+ T cell effector function, but
not recognition of local cognate antigen
To identify the cells that could display local cognate antigen, we
assessed CPXV tropism in the skin of mice infected by CPXV s.s.
There was significant recruitment of leukocytes in the skin at 6
dpi (Fig. 4 A). The majority of infected cells were MHCII/CD45
double positive and composed of mainly CD11b+ dendritic cells
(DCs) and monocyte-derived DCs (moDCs; Fig. 4, B and C). Moreover, CPXV+ and MHCII+ cells were found in close proximity to
CD8+ cells (Fig. 4 D), suggesting that CD8+ T cells may engage infected CD11b+ DCs or moDCs at the site of infection, though viral
MHCI inhibition should prevent virus-specific T cell stimulation.
Consistent with this notion, DC line DC2.4 cells infected with WT
CPXV do not stimulate IFN-γ production by CPXV-specific CD8+
T cells in vitro (Fig. 4 E). This effect is dependent on CPXV012
and CPXV203, as CPXV-specific CD8+ T cells co-cultured with
Δ12Δ203-infected DC2.4 cells produced significantly higher levels of IFN-γ and up-regulated expression of Nur77 (Fig. 4 E), a
transcription factor that is specifically induced upon TCR engagement (Moran et al., 2011). However, our results suggest that
CPXV-specific CD8+ T cells can receive antigenic stimulation at
the site of infection in vivo (Fig. 3 C).
We therefore tested if our in vitro findings extend to in vivo
infection by coinfecting IFN-γ.Thy1.1 knockin (KI) reporter mice
with WT CPXV and Δ12Δ203 on opposite flanks. Similar to our in
vitro results, CPXV s.s. resulted in significantly lower frequencies of IFN-γ–producing CD8+ T cells in WT CPXV–infected skin
in comparison to Δ12Δ203-infected skin (Fig. 4 F). Conversely,
the expression of Nur77 and the frequency of Nur77+CD8+ T cells
were not significantly different (Fig. S2 C and Fig. 4 F). We also
found similar results following coinfection of Nur77 GFP reporter
mice (Fig. S2 D). In accordance with our findings that local cognate antigen promotes TRM formation (Fig. 3 C), these findings
suggest that CD8+ T cells recruited to CPXV-infected skin receive
local cognate antigen stimulation in the context of viral MHCI inhibition. However, it still remained unclear whether CPXV-specific CD8+ T cells could recognize infected target cells in vivo, so
we performed an in vivo cytotoxicity assay. After transfer of infected targets to day 7–infected mice, ∼72% of Δ12Δ203-infected
targets were rapidly killed, whereas only ∼3% of WT-infected
targets were killed (Fig. 3, G and H). These data suggest that,
as a consequence of viral MHCI inhibition, WT CPXV–infected
targets provide little to no antigenic stimulation and may only
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tion of CD8+ TRMs in the female reproductive tract (Beura et al.,
2018). To test the role of CD4+ T cell help in the development of
CD8+ TRM in the skin, we depleted CD4+ T cells by injecting depleting antibodies 1 d before infection and then 2 and 5 dpi. This approach eliminates CD4+ T cells during acute infection but allows
for their recovery by 30 dpi. CD4+ T cell help was not required
for priming of CD8+ T cells in the presence or absence of viral
MHCI inhibition (Fig. 2, D and E). In accordance with our previous findings (Byun et al., 2009; Gainey et al., 2012), we found
that mice infected with WT CPXV by s.s. succumbed to infection
in the absence of CD4+ T cell help (Fig. 2 F), despite the mounting
an anti-CPXV CD8+ T cell response (Fig. 2 E). These results underline the capacity of CPXV to efficiently evade CD8+ T cells and
suggest that CD4+ T cell help is required to control localized CPXV
infection. In contrast, all mice infected with Δ12Δ203 survived in
the absence of CD4+ T cell help (Fig. 2 F), which is also consistent
with our previous findings that CD8+ T cells alone are sufficient
to control CPXV infection only in the absence of viral MHCI inhibition (Byun et al., 2009; Gainey et al., 2012). Given that Δ12Δ203
did not cause mortality, this provided a setting to assess the role
of CD4+ T cells in skin CD8+ TRM development. As expected, depleting CD4+ T cells during the primary response reduced the
overall number of CD4+ T cells in the skin of mice previously infected with Δ12Δ203 but did not affect the overall development
of CD4+ TRMs, since the percentage of CD103+CD4+ T cells in the
skin was similar in isotype control–treated mice (Fig. 2, G and
H). However, it is possible that these are not tissue-resident cells
and instead represent a different subset of CD4+ T cells. Surprisingly, the formation of CD8+ TRMs was augmented in the absence
of CD4+ T cell help (Fig. 2, G–I), indicating that CD4+ T cell help is
not required for the generation of skin CD8+ TRMs and may even
hinder their development.

of CD45.2+CD45.1−B819–26-tetramer+ cells in the spleen of parabiosed mice. Data are representative of three independent experiments (A–F) or were pooled
from two independent experiments (H–K). Symbols represent individual mice. Error bars represent means ± SEM. *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****,
P < 0.0001; ns, not significant; unpaired Student’s t test (A–D and I–K) or one-way ANOVA followed by Tukey’s post-test comparison (F).
Lauron et al.
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contribute minimally to local antigen-driven TRM differentiation.
Strikingly, CD103+ DCs, which are essential for cross-priming of
naive CPXV-specific CD8+ T cell precursors (Gainey et al., 2012;
Lauron et al., 2018), remain largely uninfected following CPXV
skin infection (Fig. 4 C) but were also found in close proximity to
CD8+ cells at the site of infection (Fig. 4 D). These data strongly
imply that CD8+ T cells in the skin are engaging cognate antigen
on local cross-presenting cells.
Local antigen-driven CD8+ TRM formation in the skin is limited
by viral MHCI inhibition
Infection with WT CPXV is prolonged in comparison to Δ12Δ203
infection (Gainey et al., 2012), and it is therefore possible that
during WT CPXV infection continuous recruitment of CD8+ T
cells could compensate for decreased secondary antigenic stimLauron et al.
Viral evasion of TRM immunity

ulation on skin TRM precursors. To test if continuous recruitment
of CD8+ T cells to the skin augments CD8+ TRM formation in the
presence of viral MHCI inhibition, we used the sphingosine
1-phosphate receptor-1 (S1PR) agonist FTY720, which prevents
lymphocyte egress from lymphoid and infected tissues. FTY720
treatment early during infection (1, 3, and 5 dpi) significantly reduced the presence of circulating CD8+ T cells in the blood and
the recruitment of CD8+ T cells to infected skin, but not the priming of B819–26-specific CD8+ T cells in the inguinal lymph node
(Fig. S3, A–C). FTY720 treatment also prolonged skin infection
with both WT CPXV and Δ12Δ203, as indicated by lesion scab
loss (Fig. S3, D and E), but Δ12Δ203-infected lesions still cleared
slightly faster than WT CPXV–infected lesions.
We next performed coinfections of mice with WT CPXV and
Δ12Δ203 on opposite flanks and then blocked CD8+ T cell recruitJournal of Experimental Medicine
https://doi.org/10.1084/jem.20181077
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Figure 2. Viral MHCI inhibition affects the formation of CD4+ TRMs. C57BL/6 mice were infected by s.s. with WT CPXV or Δ12Δ203. (A) Representative
flow plots of CD103 and CD69 expression on CD4+ and CD8+ cells in the skin at 35 dpi. (B) Percentage of CD103+CD69+ T cells in the skin at 35 dpi. Data are
representative of three independent experiments. (C) The absolute number of CD4+ TRMs in the skin of parabiosed mice. Parabiosis was performed as outlined
in Fig. 1 G. (D–I) Mice infected by s.s. with WT CPXV or Δ12Δ203 were treated with α-CD4 or isotype control antibodies on days −1, 2, and 5 after infection.
(D) Representative flow plots of peripheral blood T cells and B819–26-tetramer+ cells at 7 dpi. (E) Percentage of B819–26-tetramer+ cells from peripheral blood
at 7 dpi. (F) Percent survival (n = 10 mice per group). (G) Absolute number of CD4+ and CD8+ T cells in the skin at 30 dpi. (H) Percentage of CD103 expression
on T cells at 30 dpi. (I) Percentage (left) and absolute numbers (right) of B819–26-tetramer+ cells in the skin at 30 dpi. Data are pooled from two independent
experiments. Symbols represent individual mice. Error bars represent means ± SEM. **, P < 0.01, ***, P < 0.001, ****, P < 0.0001; ns, not significant; unpaired
Student’s t test (C–E and G–I) or one-way ANOVA followed by Tukey’s post-test comparison (B).

121

ment to and egress from infected skin with FTY720 treatment
starting at 7 dpi (Fig. S3 F). Starting FTY720 treatment at this later
time point also prolonged the infection on both flanks of coinfected mice, yet lesion scab loss still occurred by 15 dpi (data not
Lauron et al.
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Figure 3. Local cognate antigen enhances CD8+ TRM formation,
even in the context of viral MHCI inhibition and CD8+ T cell
evasion. (A) C57BL/6 mice were coinfected on opposite flanks by
s.s. with B819–26-sufficient (WT or Δ12Δ203) and B819–26-deficient
(B8Y3AF5A or Δ12Δ203B8Y3AF5A) CPXV. (B) Representative flow
plots of B819–26-tetramer+ cells in the skin at 7 dpi are shown above
the percentage and absolute number of B819–26-tetramer+ cells. (C)
Representative flow plots of B819–26-tetramer+ cells in the skin at 35
dpi are shown above the percentage and absolute number of B819–26tetramer+ cells. (D) Representative flow plots of CD103 and CD69
expression on CD8+ cells in the skin at 35 dpi are shown above the
percentage and absolute number of CD103+CD69+CD8+ cells. Data
are pooled from two independent experiments. Symbols represent
individual mice. Error bars represent means ± SEM. ***, P < 0.001;
****, P < 0.0001; unpaired Student’s t test.

shown). While FTY720 significantly reduced the presence of CD4+
and CD8+ T cells in the blood of coinfected mice, the relative abundance of B819–26-specific CD8+ T cells at 9 dpi and CD8+ TRMs at 40
dpi was not significantly different in WT CPXV– and Δ12Δ203Journal of Experimental Medicine
https://doi.org/10.1084/jem.20181077
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Figure 4. Viral MHCI inhibition evades CD8+ T cell
responses but does not affect TCR engagement with
cognate antigen–MHCI complexes in vivo. (A–D)
C57BL/6 mice were infected by s.s. with WT CPXV and
sacrificed on 6 dpi. (A) Absolute number of leukocytes
recruited to WT CPXV–infected skin. Cells from the skin
were gated on CD45+ and defined as follows: NK (CD3−
CD19−NK1.1+), CD19 (CD3−CD19+), CD4 (CD19−CD3+CD4+),
CD8 (CD19−CD3+CD8+), CD103+ DC (MHCII+CD11c+CD24+
SIRPα−CD103+), CD11b+ DC (MHCII+CD24+CD64−CD11b+),
Ly6C+ Mo/Mϕ (MHCII−CD64+CD11b+Ly6C+), Ly6C− Mo/
Mϕ (MHCII−CD64+CD11b+Ly6C−), moDCs (MHCII+CD11b+
CD64+CD24+), and granulocytes (MHCII−CD24+CD11b+).
Data are representative of two independent experiments.
(B) Percentage and absolute number of CPXV+ cells,
as determined by staining with α-VACV antibodies and
flow cytometric analysis. Data are representative of two
independent experiments. (C) Percentage of CPXV+ cells
within the CD45+ populations. Data are representative of
two independent experiments. (D) Immunofluorescence
staining of CD8+, CD103+, CPXV+, and MHCII+ cells in the
skin at 6 dpi. Bars, 50 µm. Data are representative of two
independent experiments. (E and F) C57BL/6 mice or
Thy1.1 KI IFN-γ reporter mice were coinfected with WT
CPXV and Δ12Δ203. The spleens of infected C57BL/6 mice
and skin of infected Thy1.1 KI IFN-γ reporter mice were
harvested for ex vivo restimulation and direct ex vivo
analyses, respectively, on 7 dpi. (E) Percentage of endogenous IFN-γ and Nur77 expression on CD8+ cells stimulated
with WT CPXV– or Δ12Δ203-infected DC2.4 cells. Data are
pooled from two independent experiments. (F) Percentage of IFN-γ (Thy1.1) and endogenous Nur77 expression on
CD8+ cells from WT CPXV– or Δ12Δ203-infected skin. Data
are pooled from three independent experiments. (G and
H) DC2.4 cells were mock infected or infected with CPXV
and used for in vivo cytotoxicity assays. Each group was
differentially labeled and transferred i.v. to naive mice (N)
or mice infected by s.s. for 7 d (I). (G) Representative flow
plots of transferred cells harvested from the lungs of recipients 4 h after transfer. (H) Percent target killing from the
in vivo cytotoxicity assay. Data are pooled from two independent experiments. Symbols represent individual mice.
Error bars represent means ± SEM. ***, P < 0.001; ****,
P < 0.0001; ns, not significant; unpaired Student’s t test.
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infected skin, with or without FTY720 treatment (Fig. S3, G and H).
These results indicate that CD8+ TRMs develop without continuous
recruitment of CD8+ T cells, which is consistent with the findings
that recruitment or inflammation alone is sufficient to induce TRM
formation (Mackay et al., 2012; Shin and Iwasaki, 2012). However,
differences in viral replication between WT CPXV and Δ12Δ203
may also influence TRM development, making it difficult to assess
the effects of viral MHCI inhibition on TRM formation.
We therefore sought to uncouple the potential effects of prolonged viral replication and the effects of viral MHCI inhibition.
To do so, we treated infected mice with the antiviral compound
cidofovir. Topical treatment with cidofovir resulted in a faster rate
of viral clearance in comparison to untreated control mice (Fig. 5,
A and B). Moreover, WT CPXV– and Δ12Δ203-infected skin lesions
Lauron et al.
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were cleared at a similar rate with cidofovir treatment, whereas
WT CPXV–infected skin lesions were cleared at a slower rate than
Δ12Δ203-infected skin lesions in untreated control mice. Interestingly, cidofovir-treated mice infected with WT CPXV or Δ12Δ203
showed no differences in the abundance of B819–26-specific TRMs,
despite simultaneous viral clearance and equal acute recruitment
of B819–26-specific CD8+ T cells in infected skin (Fig. 5 C).
We postulated that the effects of viral MHCI inhibition on
the local microenvironment might also be a confounding variable. We therefore devised a coinfection approach in which the
environment and viral replication could be better controlled in
a setting where B8 antigen presentation is or is not inhibited
by CPXV012 and CPXV203 (Fig. 5 D). For inhibited B8 antigen
presentation, we infected one flank with a 1:1 mixture of WT
Journal of Experimental Medicine
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Figure 5. Viral MHCI inhibition reduces local antigen-driven CD8+ TRM formation in the skin. (A and B) C57BL/6 mice were coinfected at adjacent sites
with WT CPXV and Δ12Δ203, treated topically with a 1% cidofovir solution, and monitored for lesion scab loss (n = 8 mice per group). (C) C57BL/6 mice were
infected by s.s. with WT CPXV or Δ12Δ203 and treated topically with cidofovir as outlined in A. Percentage of B819–26-tetramer+ cells (top) and CD103+CD69+CD8+
cells (bottom) in the skin at 7 dpi and 30 dpi. (D) C57BL/6 mice were coinfected on opposite flanks with two different mixtures of CPXV for F and G. (E) C57BL/6
mice were coinfected at adjacent sites with both mixtures. Lesion scab loss was monitored following coinfection of mice. Data are pooled from two independent
experiments (n = 9 mice per group). Viral titers from skin lesions were determined by plaque assay. Arrows indicate mice that still had lesion scabs present at the
indicated time point. (F) Percentage of CD103+CD69+CD8+ cells in the skin (S) at 35 dpi. (G) Percentage (left) and absolute number (right) of B819–26-tetramer+
cells in the skin at 35 dpi. Data are pooled from two independent experiments. Symbols represent individual mice. Error bars represent means ± SEM. ***, P <
0.001; ****, P < 0.0001; unpaired Student’s t test.
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Viral MHCI inhibition reduces the amount of antigenspecific lung CD8+ TRMs
We next assessed the effects of CPXV-mediated MHCI inhibition
on lung CD8+ TRMs, since the developmental requirements can
differ substantially between certain tissue microenvironments
(Pizzolla et al., 2017). To distinguish circulating memory CD8+ T
cells from TRMs, we performed in vivo intravascular (IV) staining (Anderson et al., 2012). This method exclusively labels circulating and IV lymphocytes (IV+ cells), but not tissue-associated
lymphocytes (IV−). Within the lung tissue, the overall proportions of IV−CD8+ T cells were equal in mice i.n. infected with WT
CPXV or Δ12Δ203 at 12 and 30 dpi, suggesting that viral MHCI
inhibition also does not affect the overall development of lung
CD8+ TRMs (Fig. 6, A and B). In contrast, higher proportions of IV−
B819–26-specific TRMs were found in the lungs following Δ12Δ203
infection compared with WT CPXV infection (Fig. 6 C). This
difference was also reflected in the spleen and blood at 30 dpi,
despite equal proportions of B819–26-specific CD8+ T cells in the
spleen and blood at 12 dpi (Fig. 6, D and E). Viral MHCI inhibition
also significantly reduced the expression of CD103 on IV− B819–26specific CD8+ T cells at 12 dpi, but not CD69 expression (Fig. 6, F
and G). The reduced expression of CD103 did not appear to affect
CD8+ TRM development, since IV− B819–26-specific CD8+ T cells in
the lungs of WT CPXV– and Δ12Δ203-infected mice expressed
comparable levels of CD69 and CD103 by 30 dpi (Fig. 6, F and G).
These data indicate that viral MHCI inhibition also reduces the
formation of antigen-specific CD8+ TRMs in the lungs.
CD8+ TRMs in the skin persist in the absence of cognate
antigen stimulation
Having established the importance of local cognate antigen in CD8+
TRM formation against CPXV, we questioned whether local cognate
Lauron et al.
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antigen plays a role after CD8+ TRM populations are established. To
address this, we generated B2mfl/flRS26-Cre-ERT2 mice in which
tamoxifen treatment ablates MHCI expression. B2mfl/flRS26Cre-ERT2 mice infected by s.s. were treated with tamoxifen at 49
dpi, and CD8+ TRMs were analyzed in the skin ∼1 mo after treatment (Fig. 7 A). Tamoxifen treatment eliminated the expression
of MHCI on CD45+ cells from the skin and spleen of B2mfl/flRS26Cre-ERT2 mice (Fig. 7 B), but not from tamoxifen-treated B2mfl/fl
littermate controls. We detected B819–26-specific TRMs at comparable levels in the skin of tamoxifen-treated B2mfl/flRS26Cre-ERT2 and B2mfl/fl mice (Fig. 7 C), indicating that persistent
antigen presentation is not required for CD8+ TRM maintenance.
This was also observed for total CD8+ TRMs in the skin (Fig. 7 D).
Furthermore, we assessed TCR engagement on CD8+ TRMs using
the Nur77 GFP reporter mice and found that CD8+ TRMs are Nur77
negative (Fig. 7 E). Therefore, CD8+ TRMs do not receive cognate
antigen stimulation in the skin and are maintained in an antigen-independent manner.
Viral MHCI inhibition evades local CD8+ TRM responses
Since viral MHCI inhibition evades CD8+ T cell responses during
primary CPXV infection, we next investigated the effects of viral
MHCI inhibition on CD8+ TRM effector function in the absence
of other anti-CPXV immune responses. To do so, we generated
a recombinant influenza virus that expresses the CPXV B819–26
epitope (Flu-B8) and infected mice by the i.n. route. This resulted in the formation of B819–26-specific TRMs in the lungs of
infected mice at 30 dpi (Fig. S4). We next challenged the mice
with CPXV at 30 dpi (Fig. 8 A). To prevent circulating memory
CD8+ T cells from contributing to viral control upon CPXV challenge, we treated Flu-B8–infected mice with FTY720 throughout
the course of the CPXV challenge. Viral titers in the lungs of mice
challenged with Δ12Δ203 were significantly lower than in mice
challenged with WT CPXV (Fig. 8 B), demonstrating that viral
MHCI inhibition abrogates protective CD8+ TRM responses in the
lungs. Furthermore, CD8+ TRM–mediated protection was antigen
dependent, since challenge with B8-deficient viruses resulted in
titers comparable to challenge with WT CPXV.
To test if these findings also hold true during CPXV skin infection, we used μMT mice in order to avoid humoral responses
against CPXV challenge, as these mice lack mature B cells. μMT
mice previously infected by s.s. with Δ12Δ203 harbored few
B819–26-specific TRMs in the skin (Fig. S5, A and B), which is consistent with the findings that infection of μMT mice generates
significantly lower numbers of memory CD8+ T cells in comparison to infection of WT C57BL/6 mice (Asano and Ahmed, 1996;
Shen et al., 2003). These findings are unlikely due to differences
in viral replication or dissemination, since Δ12Δ203 replicates
and is cleared in the μMT mice at comparable rates to C57BL/6
mice (Fig. S5, C and D). We next tested whether depleting CD4+
T cells during acute infection of μMT mice would increase CD8+
TRM formation. Similar to what we observed in WT C57BL/6
mice (Fig. 2, G–I), depleting CD4+ T cells significantly increased
CD8+ TRM formation in the skin of μMT mice infected by s.s., but
not i.n., infection (Fig. S5, A and B). In contrast, depleting CD4+ T
cells did not significantly increase the number of B819–26-specific
CD8+ T cells in the spleen of μMT mice previously infected by s.s.
Journal of Experimental Medicine
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CPXV and Δ12Δ203B8Y3AF5A. In this mix, WT CPXV provides a setting with inhibited B8 antigen presentation, while
Δ12Δ203B8Y3AF5A serves to control for the local infectious
environment and the total amount of virus per infection site
but does not contribute to B8 antigen load. For uninhibited B8
antigen presentation, we infected the opposite flank with a 1:1
mixture of Δ12Δ203 and B8Y3AF5A. Infection with Δ12Δ203
provides a source of uninhibited B8 Ag presentation, because it
lacks the CPXV MHCI inhibitors. The B8Y3AF5A virus contains
both MHCI inhibitors CPXV012 and CPXV203. It also serves as
a control for the local infectious environment and has comparable viral clearance to WT CPXV, even though it does not contribute to B8 antigen load. Therefore, the effects of viral MHCI
inhibition on the local microenvironment and the duration of
infection for each mixture should be comparable. As expected,
each mixture resulted in comparable total levels of viral replication and clearance, as determined by plaque assays and lesion
scab loss (Fig. 5 E). At 35 dpi, the abundance of CD8+ TRMs was
comparable under both conditions (Fig. 5 F). Remarkably, the
abundance of B819–26-specific CD8+ TRMs was significantly reduced when B8 Ag presentation was inhibited by CPXV012 and
CPXV203 (Fig. 5 G), indicating that viral MHCI inhibition does
indeed affect local antigen-driven TRM formation.
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Based on these findings, we induced CD8+ TRM formation in
CD4+ T cell–depleted μMT mice by s.s. with Δ12Δ203 and subsequently challenged the skin with WT CPXV and Δ12Δ203 at 30
dpi (Fig. 8 C). Viral titers in the skin of naive mice were not significantly different in WT CPXV– and Δ12Δ203-infected lesions
Lauron et al.
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Figure 6. Viral MHCI inhibition reduces the abundance of lung CD8+ TRM. C57BL/6 mice were infected i.n. with WT CPXV or Δ12Δ203. IV staining with
an anti-CD45 antibody was performed before euthanizing mice at 12 and 30 dpi. (A) Representative flow plots of CD45 expression on CD8+ cells in the lungs
(Lu). Data are representative of two independent experiments. (B) Percentage of IV−CD8+ cells in the lungs at 12 (top) and 30 (bottom) dpi. (C) Percentage of
IV−CD8+B819–26-tetramer+ cells in the lungs at 12 (top) and 30 (bottom) dpi. (D and E) Percentage of CD8+B819–26-tetramer+ cells in the spleen (Sp) and blood
(Bl) are shown at 12 and 30 dpi. (F) Representative flow plots of CD69 or CD103 expression on IV+/IV− B819–26-tetramer+ cells at 12 and 30 dpi. (G) Percentage
of CD69 and CD103 expression on IV+/IV− B819–26-tetramer+ cells at 12 (top) and 30 (bottom) dpi. Data are pooled from two independent experiments. Symbols
represent individual mice. Error bars represent means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; ns, not significant; one-way ANOVA
followed by Tukey’s post-test comparison.

4 d after challenge (Fig. 8 D). Similarly, viral titers were not significantly different in previously infected μMT mice lacking skin
CD8+ TRMs (i.n. infected). Conversely, μMT mice harboring skin
CD8+ TRMs (s.s. infected) presented viral titers that were significantly reduced by several logs in the Δ12Δ203 lesions (Fig. 8 D),
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whereas WT CPXV titers were not significantly reduced in comparison to naive and i.n.-infected mice. The differences were also
apparent by lesion formation (Fig. 8 D). These data demonstrate
that CPXV effectively evades CD8+ TRM responses, but CD8+ TRMs
can provide protection against CPXV in the absence of viral
MHCI inhibition. Intriguingly, similar results were obtained in
μMT mice that harbored fewer skin CD8+ TRMs (isotype-treated
controls), indicating that CD4+ T cell help is not required for the
generation of functional skin CD8+ TRMs (Fig. 8 E).

Discussion

In this study, we assessed the effects of viral MHCI inhibition on
the generation and function of TRMs using CPXV and the Δ12Δ203
mutant. Consistent with what was previously reported for VACV
skin infection (Khan et al., 2016; Muschaweckh et al., 2016), local
antigenic stimulation promoted CD8+ TRM formation in CPXV-infected skin, indicating that the viral MHCI inhibitors CPXV012
and CPXV203 do not completely obstruct local antigenic stimulation of CD8+ T cells or subsequent CD8+ TRM development. We
note that the duration of local antigen exposure may be shorter
throughout Δ12Δ203 infection than WT CPXV infection as a consequence of unimpeded clearance by CPXV-specific CD8+ T cells.
Lauron et al.
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Despite the potentially reduced window for antigen stimulation,
Δ12Δ203 infection in both the skin and the lung significantly
enhanced local antigen-driven TRM formation compared with
infection with WT CPXV, suggesting that early encounters with
local antigen have greater effects on TRM differentiation than the
length or persistence of antigen presentation.
Our results also suggest that local antigenic stimulation of
CD8+ T cells may promote CD8+ TRM development without eliciting T cell–mediated cytotoxicity, raising the possibility that TRM
precursors receive local antigenic stimulation from cross-presenting cells in situ (Boissonnas et al., 2013; Broz et al., 2014).
This possibility would explain why local antigen stimulation
enhances TRM formation that is not significantly affected by
the presence of viral MHCI inhibition. Since cross-presentation by BATF3+ DCs imprints TRM precursors in the lymph
nodes (Iborra et al., 2016) and is required for CPXV-specific
T cell priming (Gainey et al., 2012; Lauron et al., 2018), these
cells are candidates for involvement in local cross-presentation;
further investigation will be needed to determine their relative
contribution to in situ cross-presentation during TRM development. Intriguingly, our results also raise the possibility that local
cross-presentation may be involved in activating skin CD8+ TRM
cytokine production.
Journal of Experimental Medicine
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Figure 7. CD8+ TRMs are maintained in the
absence of cognate antigen stimulation.
B2mfl/flRS26-Cre-ERTT2 mice and B2mfl/fl littermate controls were infected by s.s. with WT CPXV.
On 49 dpi, mice were started on a tamoxifen chow
diet (TAM TX) and treated topically with 4HT
daily for 5 d. Additionally, mice were treated with
α-NK1.1 (100 µg/mouse) once weekly starting on
49 dpi to deplete NK cells. (A–D) Mice were euthanized at 76 dpi and CD8+ T cells were analyzed
in the skin (S) and spleen (Sp). (B) Representative flow plots of H-2Kb expression on CD45+ cells
from the skin and spleen on 76 dpi. (C) Percentage of B819–26-tetramer+ and CD103+CD69+ cells
in the skin and spleen at 76 dpi. (D) Percentage
of total CD8+ and CD103+CD69+ cells in the skin
at 76 dpi. Data are pooled from two independent experiments. Symbols represent individual mice. Error bars represent means ± SEM.
(E) Nur77GFP reporter mice and nontransgenic
(NTg) littermate controls were infected by s.s.
with WT CPXV and euthanized at 30 dpi. CD8+
T cells were analyzed in the skin and spleen. As
a positive control, B8 peptide was administered
intradermally and an α-CD3 antibody was administered i.v. into Nur77GFP mice previously infected
for 30 d. Representative flow plots of Nur77 (GFP)
and CD69 expression on skin and splenic CD8+
T cells are shown. Data are representative of
three independent experiments; total n = 3 positive control mice, total n = 5 Nur77GFP mice, and
total n = 6 Ntg mice. Statistical significance was
assessed using an unpaired Student’s t test (D)
or one-way ANOVA followed by Tukey’s post-test
comparison (C).
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Local antigen presentation by APCs is critical for the activation of CD8+ TRMs in the female genital tract and central nervous
system (Wakim et al., 2010; Shin et al., 2016), but direct contact
with infected target cells is not necessarily required for CD8+
TRM–mediated protection. For instance, in situ peptide stimulation of CD8+ TRMs is sufficient to induce a tissue-wide antiviral
state and protects against antigenically distinct viruses (Ariotti
et al., 2014; Schenkel et al., 2014). Therefore, CD8+ TRM activation
and protection can ensue independently of direct cell–cell contact with infected target cells. We found that CD8+ TRM protection
during viral infection is abrogated by viral MHCI inhibition, indicating that TCR/peptide-MHCI (pMHCI) stimulation via engagement of infected target cells is needed for optimal CD8+ TRM
functions. We also found that CD4+ T cell help was not required
for the generation of functional skin CD8+ TRMs and that the absence of CD4+ T cell help increased skin CD8+ TRM formation. As
TRMs have been shown to compete within epidermal niches (Zaid
et al., 2014), it is possible that the absence of CD4+ T cells during
Lauron et al.
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acute infection reduces competition for local survival signals and
space, lessening the constraints on the number of CD8+ TRMs.
Additionally, we show CD8+ TRM development in the lungs of
CPXV-infected mice remained largely unaffected by viral MHCI
inhibition, but viral MHCI inhibition reduced the abundance of
antigen-specific lung TRMs. The induction of CPXV-specific CD8+
T cell responses is not affected by viral MHCI inhibition during
primary CPXV infection (Gainey et al., 2012; Lauron et al., 2018),
but the breadth and the levels of viral epitopes presented in this
context can differ from those presented in the absence of viral
MHCI inhibition (Basta et al., 2002; Shen et al., 2002). As a consequence, increased antigen presentation and antigen abundance
during respiratory infection with Δ12Δ203 potentially promotes
CD8+ T cell cross-competition for pMHCI complexes, which can
affect the TRM repertoire (Muschaweckh et al., 2016; Pizzolla et
al., 2017). These findings were not found following CPXV skin
infection, suggesting that differences in the microenvironment
also play a role in the development of antigen-specific TRMs; we
Journal of Experimental Medicine
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Figure 8. Viral MHCI inhibition evades protective CD8+ TRM responses. (A) Schematic of the heterologous prime/challenge experiment. (B) Viral titers in
the lungs of Flu-B8–immunized mice challenged with CPXV. Data are pooled from two independent experiments. (C) Schematic of μMT mice skin challenge
experiment. (D) Image of infected flanks and viral titers from skin lesions 4 d after s.s. challenge of α-CD4–treated naive control and CPXV-immunized μMT
mice. (E) Viral titers from skin lesions 4 d after s.s. challenge of isotype control–treated CPXV-immunized μMT mice. Data are pooled from two (B) or three
(D and E) independent experiments. Symbols represent individual mice. Error bars represent means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P <
0.0001; ns, not significant; one-way ANOVA followed by Tukey’s post-test comparison.
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Materials and methods

Mice, cell lines, and viruses
C57BL/6 mice were purchased from the National Cancer Institute. Transgenic and knockout mice were purchased from The
Lauron et al.
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Jackson Laboratory, with the exception of B2mfl/fl and IFNγ KI
Thy1.1 mice. IFNγ KI Thy1.1 mice were provided by Dr. Casey
Weaver (University of Alabama School of Medicine, Birmingham, AL). B2mfl/fl mice were generated as described by Bern
et al. (2018). DC2.4 cells were cultured in RPMI supplemented
with 10% FBS (Mediatech), 100 U/ml penicillin, 100 g/ml streptomycin, 1 mM sodium pyruvate, L-glutamine, and nonessential
amino acids (Gibco). Madin–Darby Canine Kidney (MDCK) and
Vero cells were maintained in MEM with 5% FBS, MEM vitamins
(Gibco), L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. Human embryonic kidney cells (293T) were maintained
in Opti-MEM (Life Technologies) with 10% FBS, L-glutamine, 100
U/ml penicillin, and 100 g/ml streptomycin. DC2.4 cells were a
gift from Dr. Kenneth Rock (University of Massachusetts Medical School, Worchester, MA). MDCK and 293T cells were a gift
from Dr. Richard Webby (St. Jude Children’s Research Hospital,
Memphis, TN). Vero cells were obtained from the American Type
Culture Collection.
For the generation of IAV-B819–26 (Flu-B8), the CPXV B819–26
epitope was inserted into the stalk region of neuraminidase,
in-frame, between nucleotides 148 and 170 using inverse PCR
(Phusion-HF; Thermo Fisher) and the restriction enzyme AarI
(Thermo Fisher) to ligate the mutant plasmid. Co-cultures of
293T and MDCK cells were transfected with eight bidirectional
pHW2000 plasmids containing cDNA for A/Puerto Rico/08/1934
(H1N1; 1 µg per plasmid) with polyethylenimine (8 µg total). Rescue of the reverse genetic virus was performed as previously described (Williams et al., 2018).
Bacterial artificial chromosome–derived CPXV viruses were
generated as previously described (Lauron et al., 2018). To determine viral titers, tissues were processed as previously described
(Gainey et al., 2012). In brief, harvested tissues were placed in
1 ml MEM, homogenized using a MiniBeadbeater-8, and stored
at −80°C. Samples were then serially diluted for plaque assays
using Vero cells.
Mouse infection and parabiosis surgery
Mice 8–10 wk of age were sex and age matched for each experiment. i.n. and s.s. infections were performed as previously described (Gainey et al., 2012). In brief, mice were anesthetized,
and 30 µl of virus inoculum diluted in PBS was administered
i.n. For s.s., fur from the flank of mice was depilated using Nair.
The following day, mice were anesthetized and the flanks were
infected by s.s. at three adjacent sites with 105 PFU per site. Parabiosis surgery was performed as previously described (Peng et
al., 2013; Sojka et al., 2014). Parabiosed mice were rested for 2
wk before sacrificing and harvesting tissues. Mouse studies were
approved by the Animal Studies Committee at Washington University (protocol #A-3381-01) and adhered to the Institutional
Animal Care and Use Committee guidelines.
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did, however, observe an effect in the skin when we experimentally controlled for environmental conditions. Moreover, respiratory viral infections result in persistent antigen presentation
(Zammit et al., 2006; Jelley-Gibbs et al., 2007; Turner et al., 2007)
and can contribute to the locality of memory T cells (Kim et al.,
2010). Persistent antigen presentation was therefore an appealing explanation for the generation and long-term maintenance
of TRMs in peripheral tissues.
Here, we used inducible deletion of B2m to test if persistent
antigen stimulation is required for maintaining skin TRMs. We
found that deletion of B2m after TRM formation did not affect the
number of TRMs, suggesting that local cognate antigen or even
low-level stimulation from cross-reactive pMHCI complexes is
not required for TRM maintenance. However, since our studies
focused on the CD45+ compartment, it is possible that low-level
expression of MHCI on nonhematopoietic cells could contribute
to TRM maintenance. Nonetheless, our results add to previous reports (Casey et al., 2012; Mackay et al., 2012; Shin and Iwasaki,
2012; Davies et al., 2017; Slütter et al., 2017) by suggesting that
TRM maintenance is also apparently independent of cross-reactive pMHCI complexes.
Collectively, our findings shed light on the maintenance, generation, and activation of CD8+ TRMs and highlight the effects of
viral MHCI inhibition on TRM biology. The effects of viral MHCI
inhibition on CD8+ T cells can be difficult to demonstrate, as most
of the identified viral MHCI inhibitors exhibit varying degrees
of species specificity and efficacy across MHCI allomorphs (Cox
et al., 1994; Le Gall et al., 1998; Rehm et al., 2002; Wagner et al.,
2002). Remarkably, CPXV012 and CPXV203 potently act on both
murine and human MHCI molecules, and the in vivo effects on
CD8+ T cell responses are evident. The CPXV infection model
thus provides a unique opportunity to investigate the effects of
viral immune evasion on antiviral CD8+ T cell development and
effector functions. Although we demonstrate that CPXV-mediated MHCI inhibition evades CD8+ TRM responses, the relevance
of skin TRM responses following CPXV reinfection of its natural wild rodent hosts or humans is unclear. For instance, skin
TRMs would only be activated if CPXV reinfection occurred at
or by sites of previous infections where TRMs have formed. In
contrast, TRMs may be relevant for natural CPXV reinfections
acquired through respiratory routes, where lung TRMs are more
likely to reencounter viral antigens. In the case of the later, the
role CPXV012 and CPXV203 would certainly be advantageous
for the virus. Given the efficacy of CPXV012 and CPXV203, it is
likely that CPXV-mediated MHCI inhibition also contributes to
the evasion of TCMs and TEMs, but we did not directly test this.
Nonetheless, our study demonstrates a proof of concept that
viral inhibition of MHCI antigen presentation can affect memory
CD8+ T cell development and responses, which should be considered in regards to vaccine design against viruses that target
the MHCI pathway.

Immunofluorescence
A 2 × 3 cm2 piece of skin was harvested from infected mice and
prepared as previously described (Hsu et al., 2009). Sections
were blocked using 10% goat serum in PBS for 1 h before incubating with primary antibodies for 1 h. Cells were then washed
with 0.5% Triton in PBS, incubated with Streptavidin-AF555
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(Thermo Fisher), washed with 0.5% Triton in PBS, and mounted
with DAPI (Vectashield). Stained sections were analyzed with
a laser scanning confocal microscope (LSM880; Zeiss). Primary antibodies were obtained from BD PharMingen and include CD103-Biotin (M290), IA/IE-AF647 (M5/114.15.2), and
CD8α-AF488 (53–6.7).

Flow cytometry, intracellular cytokine staining, antibodies,
and cell sorting
Single-cell suspensions from the spleens, lymph nodes, and
lungs and an ∼2 × 3 cm2 piece of skin were prepared at the indicated days after infection as previously described (Gainey et
al., 2012; Jiang et al., 2012). Skin and lung tissues were minced
and incubated in with HBSS containing 1 mg/ml collagenase
A (Roche) and 22.4 g/ml DNase I (Roche) at 37°C for 30 min.
Samples were then filtered through a 70-µm mesh strainer before staining. For IL-10 staining, cells were incubated in RPMI
containing GolgiPlug (BD Biosciences) at 37°C for 2 h before
staining. Samples for flow cytometric analyses were stained on
ice with Fixable Viability Dye eFlour 506 (eBioscience) before
tetramer and cell surface staining. For tetramer staining, cells
were incubated with tetramers for 45 min at room temperature
before cell surface staining of the indicated surface markers. Tetramers were produced in the Immunomonitoring Laboratory
within the Center for Human Immunology and Immunotherapy Programs (Washington University). Ex vivo restimulation
and intracellular cytokine staining for IFN-γ was performed
as previously described (Lauron et al., 2018). For staining of
Nur77, the Foxp3/Transcription Factor Staining Buffer Set was
used according to the manufacturer’s protocol (eBioscience).
The following antibodies were purchased from Abcam, BD
Biosciences, eBioscience, BioLegend, or Thermo Fisher: CD3
(145-2C11), NK1.1 (PK136), CD19 (eBio1D3), CD64 (X54-5/7.1),
CD8α (53–6.7), CD4 (RM4-5), VACV (Ab19970), CD4 (RM4-4),
CD44 (IM7), CD103 (2E7), CD69 (H1.2F3), H-2Kb (AF-88.5),
CD11c (N418), CD45.1 (A20), CD45.2 (104), CD24 (M1/69), IA/IE
(M5/114.15.2), SIRPα (P84), CD11b (M1/70), Ly6C (HK1.4), Nur77
(12.14), and IL-10 (JES5-16E3). Cell sorting was performed on a
BD FACSAria Fusion sorter.
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In vivo cytotoxicity assay
Mice were infected by s.s. with WT CPXV. At 6 dpi, infected
mice and naive controls were injected i.p. with 200 µg/mouse
of α-NK1.1. At 7 dpi, DC2.4 cells were mock-infected or infected
with CPXV (multiplicity of infection of 2) and incubated at 37°C
for 2.5 h. Cells were then washed with PBS and costained with
CellTrace Far Red dye and either 20 µM, 4 µM, or 0.8 µM CellTrace Violet dye (Thermo Fisher). Labeled cells were transferred
i.v. (106 cells per group) into naive mice or day 7–infected mice.
After 4 h, the lungs were harvested as described above and cells
were examined by flow cytometry. Far Red+ cells were gated, and
the percent killing was calculated using the following formula:
100 − ([(% infected cells in infected mice/% mock-infected in infected mice)/(% infected cells in naive mice/% mock-infected in
naive mice)] × 100).
Statistical analysis
The data were analyzed with an unpaired Student’s t test or oneway ANOVA followed by Tukey’s post-test comparison using
Prism GraphPad software.
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In vivo antibody, FTY720, cidofovir, and tamoxifen treatment
To induce TCR ligation in vivo, 50 µg anti-CD3e monoclonal antibody (145-2C11; Thermo Fisher) was administered into mice by i.v.
injection 16 h before harvesting tissues. FTY720 (Cayman Chemical) was administered by i.p. injection (10 mg/kg) in aqueous
solution. A 1% cidofovir solution (Sigma-Aldrich) was prepared
in DMSO, and 16 µl per lesion was applied topically on 3 dpi and
twice daily for the remaining time points indicated. To deplete
CD4+ T cells, 200 µg anti-CD4 (GK1.5) or isotype control (anti-rat
IgG2b; Bio X Cell) was injected i.p. To deplete natural killer (NK)
cells, 100 µg anti-NK1.1 (PK136) was injected i.p. weekly. For IV
staining, fluorochrome-conjugated anti-CD45.2 (104; BioLegend)
was administered by i.v. injection. 3 min after injection, mice
were sacrificed, and tissues were harvested. Mice were treated
topically with 1 mg 4-hydroxytamoxifen (Sigma-Aldrich) dissolved in ethanol and were fed a tamoxifen diet (Envigo) during
the indicated times shown.

RNA isolation and RNA-seq analysis
B819–26-specific CD8+ T cells (LIVE/DEAD−CD4−CD45.2+CD3+CD8+CD44+B819–26-tetramer+) were sorted from the spleen and
skin of mice coinfected on opposite flanks with WT CPXV and
Δ12Δ203 at 7 dpi. Cells were pooled from five mice per experiment to reach at least 20,000 cells per sample. RNA was extracted using the Arcturus PicoPure RNA Isolation kit according
to the manufacturer’s protocol (Thermo Fisher). mRNA-seq libraries were created using SMARTer cDNA synthesis technology
(Clontech), indexed, pooled, and sequenced at the Genome Technology Access Center (GTAC) at Washington University School
of Medicine (St. Louis, MO). Sequencing was run as paired-end
reads of 100 bp on the Illumina HiSeq 2500 platform. Raw reads
were deposited in the National Center for Biotechnology Information Sequence Read Archive (BioProject ID: PRJNA498691;
BioSample accession nos. SAMN10330286, SAMN10330287,
SAMN10330288, SAMN10330289, SAMN10330290, and
SAMN10330291). Basecalls and demultiplexing were performed
with Illumina’s bcl2fastq software and a custom python demultiplexing program with a maximum of one mismatch in the
indexing read. RNA-seq reads were then aligned using STAR
aligner (Dobin et al., 2013). Gene counts were derived from the
number of uniquely aligned unambiguous reads by Subread:
featureCount (Liao et al., 2014) and subsequently analyzed using
DESeq2 (Love et al., 2014). GSEAs were performed using the GenePattern module GSEAPreranked.

Online supplemental material
Fig. S1 shows that skin CD8+ T cells up-regulate local IL-10 production during acute CPXV infection. Fig. S2 shows that local
antigen recognition up-regulates CD69 and Nur77 expression by
CD8+ T cells. Fig. S3 shows that CD8+ TRMs develop without continuous recruitment of CD8+ T cells during acute CPXV infection.
Fig. S4 shows that Flu-B8 respiratory infection generates B819–26specific CD8+ TRMs in the lungs. Fig. S5 shows that the number of
CD8+ TRMs is reduced in B cell–deficient mice.
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